GT BIOPHARMA INC's ticker is GTBP and the CUSIP is 36254L209. A total of 36 filers reported holding GT BIOPHARMA INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $12,055 | -22.7% | 50,000 | 0.0% | 0.00% | – |
| Q2 2023 | $15,600 | -43.3% | 50,000 | 0.0% | 0.00% | -100.0% |
| Q1 2023 | $27,500 | -38.9% | 50,000 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $45,000 | -48.9% | 50,000 | 0.0% | 0.00% | -66.7% |
| Q3 2022 | $88,000 | -2.2% | 50,000 | +66.7% | 0.00% | +50.0% |
| Q2 2022 | $90,000 | +4.7% | 30,000 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $86,000 | -6.5% | 30,000 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $92,000 | -8.9% | 30,000 | +100.0% | 0.00% | 0.0% |
| Q3 2021 | $101,000 | -56.7% | 15,000 | 0.0% | 0.00% | -60.0% |
| Q2 2021 | $233,000 | – | 15,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Gordian Capital Singapore Pte Ltd | 35,000 | $107,000 | 0.08% |
| Crumly & Associates Inc. | 32,163 | $85,000 | 0.03% |
| Anson Funds Management LP | 43,692 | $133,000 | 0.01% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 23,106 | $70,000 | 0.01% |
| Investmark Advisory Group LLC | 1,450 | $4,000 | 0.00% |
| Welch Group, LLC | 10,000 | $31,000 | 0.00% |
| SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC | 28,860 | $88,000 | 0.00% |
| Compagnie Lombard Odier SCmA | 30,000 | $92,000 | 0.00% |
| BRIGHTON JONES LLC | 11,288 | $34,000 | 0.00% |
| TWO SIGMA ADVISERS, LP | 119,900 | $366,000 | 0.00% |